KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY
发明人:
CHO, Kwang Hyun,조광현,CHOI, Min Soo,최민수,JUE, Shi
申请号：
KRKR2012/010659
公开号：
WO2014/073740A1
申请日:
2012.12.07
申请国别(地区):
WO
年份:
2014
代理人:
摘要：
The present invention provides an anti-tumor drug comprising, as active ingredients, Wip1 inhibitors and Mdm-2/p53 interaction inhibitors so as to effectively treat malignant tumors.La présente invention concerne un médicament anticancéreux comprenant, comme principes actifs, des inhibiteurs de la Wip1 et des inhibiteurs de linteraction Mdm-2/p53 afin de traiter efficacement les tumeurs malignes.본 발명은 악성종양의 효과적인 치료를 위하여, Wip1 저해제 및 Mdm-2/p53 상호작용 저해제를 유효성분으로 함유하는 종양 치료제를 제공한다.
